- £1.18bn
- £1.42bn
- £689.70m
- 52
- 21
- 33
- 25
Annual income statement for Genus, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2019 June 30th | R2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 489 | 551 | 574 | 593 | 690 |
| Cost of Revenue | |||||
| Gross Profit | 179 | — | — | — | — |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 480 | 509 | 527 | 544 | 649 |
| Operating Profit | 8.7 | 42.4 | 47.7 | 49.4 | 40.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 9.9 | 46.3 | 55.8 | 48.4 | 39.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.7 | 35.7 | 46.8 | 36.7 | 31.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 7.8 | 35.3 | 47.3 | 40.9 | 33.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 7.8 | 35.3 | 47.3 | 40.9 | 33.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.509 | 0.637 | 0.9 | 0.711 | 0.754 |
| Dividends per Share |